Tianchen Biotechnology Funding: $42M Raised, Series A (2024)
Tianchen Biotechnology is based in Tianjin, China. It has raised $42M in total funding. Latest round: Series A.
Tianchen Biotechnology funding overview
Tianchen Biotechnology is based in Tianjin, China. Tianchen Biotechnology has raised $42M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2024. The round record for Tianchen Biotechnology runs through 2024; nothing later has been disclosed. Investors on record include Qiming Venture Partners, Oriental Fortune Capital, Shanxi Securities. 3 distinct backers are named across the disclosed rounds.
Frequently asked about Tianchen Biotechnology funding
How much has Tianchen Biotechnology raised?
Tianchen Biotechnology has raised $42M in total disclosed funding across the rounds on record.
Who has invested in Tianchen Biotechnology?
Qiming Venture Partners, Oriental Fortune Capital, Shanxi Securities are named among the investors backing Tianchen Biotechnology.
What was the latest Tianchen Biotechnology funding round?
The most recent disclosed round is a Series A, announced in March 2024.
Where is Tianchen Biotechnology based?
Tianchen Biotechnology is based in Tianjin, China.
When did Tianchen Biotechnology last raise?
The last disclosed Tianchen Biotechnology round closed in March 2024 at Series A.
Tianchen Biotechnology totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Tianjin below to benchmark round size and investor mix.
